Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06649110 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
A Phase 1 study of Healthy Volunteers, Pulmonary Arterial Hypertension, sponsored by Novartis Pharmaceuticals.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 232
- Enrollment target
- 20
- Study locations
NCT06649110 is a Phase 1 study of Healthy Volunteers, Pulmonary Arterial Hypertension that is actively recruiting participants, run by Novartis Pharmaceuticals. The registered enrollment target is 232 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT06649110, a Phase 1 study of Healthy Volunteers, Pulmonary Arterial Hypertension, is actively recruiting participants, sponsored by Novartis Pharmaceuticals.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 232 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG LTP
Study Locations (20)
Other
- Novartis Investigative Site - Prague
- Novartis Investigative Site - Berlin
- Novartis Investigative Site - Heidelberg
- Novartis Investigative Site - Thessaloniki
New South Wales
- Novartis Investigative Site - Camperdown
- Novartis Investigative Site - Darlinghurst
- Novartis Investigative Site - New Lambton Heights
California
- Stanford Medical Center - Stanford
Colorado
- Univ Colorado Hospital - Aurora
Kansas
- U of Kansas Medical Center - Kansas City
Kentucky
- Norton Infectious Diseases Specialists - Louisville
Massachusetts
- Tufts Medical Center - Boston
Oregon
- Summit Health Eastside Clinic - Bend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2024-10-24 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06649110
The ClinicalTrials.gov registry entry for NCT06649110 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers, Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06649110 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Other, New South Wales, California.
Frequently Asked Questions
What is clinical trial NCT06649110 about?
NCT06649110 is a clinical study titled "A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)". A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
What is the current status of trial NCT06649110?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 232 participants. The study started on 2024-10-24. Estimated completion is 2028-12-31.
What conditions does trial NCT06649110 study?
This clinical trial studies the following conditions: Healthy Volunteers, Pulmonary Arterial Hypertension.
What interventions are being tested in trial NCT06649110?
The interventions under investigation include: Placebo (DRUG), LTP (DRUG).
Who is sponsoring clinical trial NCT06649110?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06649110 being conducted?
This trial has 20 study locations across California, Colorado, Kansas, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.